DOD Taps Continuus for Onshore Production of Active Pharmaceutical Ingredients
Continuus Pharmaceuticals has secured a $69.3M contract with the Department of Defense to use its integrated continuous manufacturing technology for developing critical active pharmaceutical ingredients and final dosage form medicines used for COVID-19 treatment.